Where IL-15 Sits in the Cell-Therapy Pipeline: Four Translational Routes and Their Evidence
IL-15 supports NK and T-cell therapy programs through four translational routes: ex vivo expansion, in vivo persistence, IL-15Ralpha-Fc fusions and superagonists.
- Recent Advances
- Product Information
Recent Advances
Abstract: IL-15 supports NK and T-cell therapy programs through four translational routes: ex vivo expansion, in vivo persistence, IL-15Ralpha-Fc fusions and superagonists.
Keywords: IL-15, cell therapy, NK cell, IL-15Ralpha-Fc, superagonist, memory T cell, UA040010
Note: The full article is published in Chinese. Please refer to the Chinese version for complete experimental details, figures and product references. For product inquiries, visit www.ua-bio.com.
Product Information






